![]() Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. | ![]() Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. | ![]() Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease. | |
Founding Date | Founding Date 2017 | Founding Date 2014 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Carlsbad, US HQ | Locations New York, US HQ Copenhagen, DK Nutley, US | Locations New York, US HQ |
Employees | Employees 54 | Employees 3239% increase | Employees 489% increase |
Valuation ($) | Valuation ($) 313.1 m | Valuation ($) 657 m | Valuation ($) 787.7 m |
Financial | |||
Net income | Net income ($69.8m) (FY, 2025) | Net income ($29.7m) (FY, 2024) | Net income ($63.2m) (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 80m | Total funding raised $ 125m |

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
View company
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
View company